Home › Free Stock Grades › NVCR
Novocure Ltd (NVCR) Stock Grade
NVCR · Healthcare
C
Market Cap
$1.8B
P/E Ratio
—
Revenue Growth (YoY)
+8.3%
Net Margin
-20.8%
Return on Equity
—
Dividend Yield
None
About Novocure Ltd's fundamentals
Novocure is a medical device company with a market capitalization of $1.8 billion that is growing revenue at a rate of 8.3% year-over-year. However, the company is currently unprofitable, operating with a net margin of -20.8%, and reported a net loss in its latest annual statement. The company does not pay a dividend to shareholders. With negative profitability metrics, traditional valuation ratios like P/E and return on equity are not applicable.